PI Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
PI Industries Ltd · Outcome · 05 Nov 2026, 1:08 am
PI Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 17,018 (-9.1% YoY | +0.0% QoQ) ■ EBITDA: 2,327 (-57.0% YoY | -36.7% QoQ) ■ EBITDA Margin (%): 13.7 (-1524 bps YoY | -791 bps QoQ) ■ PAT: 1,222 (-70.1% YoY | -50.0% QoQ) ■ EPS (INR): 8.05 (-70.2% YoY | -50.0% QoQ) PI Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Agro chemicals ■ Revenue: 16,280 (-10.0% YoY | -1.3% QoQ) ■ EBIT: 2,473 (-58.1% YoY | -35.5% QoQ) ■ EBIT Margin (%): 15.2 (-1746 bps YoY | -807 bps QoQ) Pharma ■ Revenue: 759 (+19.7% YoY | +40.0% QoQ) ■ EBIT: -601 (+26.6% YoY | +26.3% QoQ) ■ EBIT Margin (%): -79.2 (+5000 bps YoY | +7137 bps QoQ)
Original exchange filing (PDF)
More announcements from PI Industries Ltd
- Intimation for interaction with ICICI Prudential Asset Management Company Limited · 13 Nov 2026
- Transcript of the Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2026 · 12 Nov 2026
- Audio Recording of Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2026 · 05 Nov 2026
- Presentation of Earnings Conference Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2026 · 05 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 · 05 Nov 2026
- PI Industries Limited has submitted to the Exchange, the Outcome of Board Meeting held on November 04, 2026 for approval of Unaudited Standalone and Consolidated Financial Results for the quarter and half year September 30, 2026. · 05 Nov 2026
- PI Industries Limited has informed the Exchange about Press Release regarding unveiling of Pioxaniliprole, India's first indigenously discovered insecticide molecule. · 29 Oct 2026
- Earnings Conference Call with Analysts / Investors for the quarter and half year ended September 30, 2026 · 05 Nov 2026
